ARCHIVES

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 22 | June 1, 2001

Download PDF Visit The Full Archive

Related Articles

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

The March To Deliver Message Of Funding For Cancer Research, Access To Care

September 4, 1998

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

Organ Site Program Fate On Line, Gets Review Next Week

November 20, 1981

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011